肝脏ChREBP相互调节NAFLD中的全身胰岛素敏感性
Aniket Sen1, Shilpa Thakur1, Priya Rawat2
1School of Biosciences and Bioengineering, IIT Mandi, Mandi, India.
The Journal of biological chemistry
|May 1, 2025
概括
减少肝脏ChREBP通过降低PTEN和增加FGF21来提高胰岛素敏感性. 小分子Quercetin模仿这种效应,为NAFLD和T2DM的胰岛素抵抗提供潜在的保护.
科学领域:
- 代谢调节 代谢调节 代谢调节
- 分子生物学分子生物学
- 肝病学 肝病学是一种肝病学.
背景情况:
- 碳水化合物敏感元素结合蛋白 (ChREBP) 在肝脏胰岛素敏感性中的作用尚未完全理解.
- 胰岛素抵抗是代谢障碍的标志,如非酒精性脂肪性肝病 (NAFLD) 和2型糖尿病 (T2DM).
研究的目的:
- 为了研究肝脏ChREBP对胰岛素敏感性的影响.
- 确定将ChREBP与胰岛素耐药性联系起来的分子机制.
- 探索针对ChREBP治疗代谢疾病的治疗策略.
主要方法:
- 使用高脂肪和糖养的小鼠模型与肝脏ChREBP敲击.
- 通过ChREBP对PTEN的转录调节进行了研究.
- 分析了FGF21释放和全身胰岛素敏感性.
- 采用分子动力学模拟来识别针对ChREBP的小分子.
- 在体内测试了Quercetin的疗效.
主要成果:
- 肝脏ChREBP减弱显著改善了小鼠的胰岛素敏感性.
- ChREBP直接驱动肝脏PTEN的转录诱导.
- 降低的PTEN水平促进肝脏胰岛素敏感性,增强FGF21释放,改善全身胰岛素敏感性.
- 奎尔素有效地将ChREBP隔离在细胞质中,防止其核转位,并模仿ChREBP敲击的胰岛素敏感作用.
结论:
- 肝脏ChREBP是系统性胰岛素信号的关键调节器.
- 降低ChREBP的调节提供了针对胰岛素耐药性的保护机制.
- 奎尔赛丁是一种潜在的治疗药物,可以通过向肝脏ChREBP来控制胰岛素抵抗.
相关概念视频
01:58Cell Specific Gene Expression
13.5K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.5K
01:29Cholesterol: Significance and Regulation
520
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
520
01:28Insulin: The Receptor and Signaling Pathways
1.2K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.2K
01:29Chronic Pancreatitis II: Collaborative Care
77
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
77
01:24Chronic Pancreatitis I: Introduction
84
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
84
01:30Liver Physiology
456
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
456